Drug profile · INN
emicizumab
HEMLIBRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
emicizumab (HEMLIBRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN emicizumab
Brand HEMLIBRA
Route INJECTION
Formulation INJECTABLE
ATC code B02BX06
Frequently asked questions
What is emicizumab?
emicizumab (HEMLIBRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for emicizumab?
HEMLIBRA is a marketed brand name for emicizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of emicizumab?
emicizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.